Dresden / Dallas / Cork / Leiden / Munich / Wuppertal / Helsinki / Boston / Hamilton / Zuehlsdorf / Calgary / London / Perugia / /
Company
Berg-Segers AE / Bayer HealthCare AG / Central Adjudicating Laboratory / American Heart Association Inc. / Statistical Solutions Ltd / ITT / GlaxoSmithKline / Merck / Borris LC / Segers AE / Lilly / GE / Pfizer / Turpie AG / HP / AstraZeneca / Bayer AG / /
Country
Netherlands / Canada / Australia / United Kingdom / Germany / Italy / Ireland / / /
Event
FDA Phase / Person Communication and Meetings / Product Recall / Product Issues / /
Facility
Foothills Hospital / Leiden University Medical Center / McMaster University / Thrombosis Research Institute / University Hospital Carl Gustav Carus / Central Adjudicating Laboratory / University of Perugia / Henderson Research Centre / Women’s Hospital / Flinders University / /
IndustryTerm
online version / contrast media / food / therapy for venous thromboembolic disease / standardized examination protocol / food interactions / rivaroxaban treatment / /
MedicalCondition
acute hepatitis B / symptomatic acute thrombosis / recurrent venous thromboembolism / disseminated intravascular coagulation / brain metastasis / hepatitis B / disorder / venous thromboembolic disease / active peptic ulcer / deep-vein thrombosis / severe heart failure / pneumonia / Patients With Acute Symptomatic Deep-Vein Thrombosis / deep venous thrombosis / thromboembolism / acute / symptomatic deep vein thrombosis / recurrent symptomatic venous thromboembolism / septicemia / sarcoma / deep vein thrombosis / diseases / active cancer / infection / proximal deep-vein thrombosis / inflammatory / fibrosis / liver failure / established thrombosis / symptomatic deep venous thrombosis / severe inflammatory bowel disease / proximal deep vein thrombosis / carcinoma / thromboembolic disorders / acute proximal deep-vein thrombosis / pulmonary embolism / recurrent thromboembolism / leg vein thrombus / acute liver failure / liver metastases / disease / cerebral ischemia / Proximal Vein Thrombosis / venous thrombosis / short gut syndrome / Acute Symptomatic Deep-Vein Thrombosis / venous diseases / uncontrolled severe hypertension / lung cancer / metastatic cancer / venous thromboembolism / thrombus / thrombosis / anemia / /
MedicalTreatment
surgery / radiation / contraception / orthopaedic surgery / orthopedic surgery / total knee replacement / neurosurgery / chemotherapy / total hip replacement / thrombolytic therapy / /
NaturalFeature
Direct Factor Xa Inhibitor BAY / De Sanctis MT / /
Organization
Committee for Proprietary Medicinal Products / Institute for Experimental Oncology and Therapy Research / London School of Medicine / Foothills Hospital / Division of Internal and Cardiovascular Medicine / New York Heart Association / Henderson Research Centre / Thrombosis Research Institute / Flinders University / Adelaide / Flinders Medical Centre / Harvard Medical School / McMaster University / University Hospital / Leiden University Medical Center / CCUS Adjudication Committee / Women’s Hospital / Editorial Office / European Agency for the Evaluation of Medicinal Products / Copyright Clearance Center / Independent Data Safety Monitoring Board / Faculty of Health Sciences / American Heart Association / Division of Internal / University of Perugia / /
Person
Ajay K. Kakkar / Sebastian Schellong / Alexander Gallus / Kim JR / Giancarlo Agnelli / Frank Misselwitz / E. Muehlhofer / S. Maria della Misericordia / Sylvia Haas / Samuel Z. Goldhaber / Menno V. Huisman / Arch Intern / Fondaparinux vs / Ann Intern / Alan T. Hirsch / /